INJ Eyes $3.50-$4.20 Rally by April 2026

Injective (INJ) targets a strong recovery, aiming for $3.50 to $4.20 by April 2026 according to MEXC forecasts. Analysts predict this bounce from current levels around $2.80-$3.00, fueled by positive market trends and technical indicators. Various projections align, with some seeing highs up to $4.70 or even $10.60 in optimistic scenarios, while averages hover near $3.00. Traders eye Q2 momentum for gains up to 268% ROI. Read more about this...